News and Trends 27 Mar 2019
Genfit Gets Ready to Launch Drug for Untreated Liver Disease Raising €120M
After some big failures from its top competitors earlier this year, French company Genfit has done an IPO to prepare the launch of its drug for NASH, a chronic liver disease for which there is currently no treatment. Today, Genfit has started trading on Nasdaq. Together with issuing new shares in its existing Euronext Paris […]